Use of artificial cells as drug carriers

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversity of California-
Autor(es): dc.contributorEskisehir Technical University-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorMichigan State University-
Autor(es): dc.contributorUniversity of Tartu-
Autor(es): dc.creatorEmir Diltemiz, Sibel-
Autor(es): dc.creatorTavafoghi, Maryam-
Autor(es): dc.creatorDe Barros, Natan Roberto-
Autor(es): dc.creatorKanada, Masamitsu-
Autor(es): dc.creatorHeinämäki, Jyrki-
Autor(es): dc.creatorContag, Christopher-
Autor(es): dc.creatorSeidlits, Stephanie K.-
Autor(es): dc.creatorAshammakhi, Nureddin-
Data de aceite: dc.date.accessioned2025-08-21T19:45:29Z-
Data de disponibilização: dc.date.available2025-08-21T19:45:29Z-
Data de envio: dc.date.issued2022-04-28-
Data de envio: dc.date.issued2022-04-28-
Data de envio: dc.date.issued2021-09-21-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1039/d1qm00717c-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/222464-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/222464-
Descrição: dc.descriptionCells are the fundamental functional units of biological systems and mimicking their size, function and complexity is a primary goal in the development of new therapeutic strategies. Recent advances in chemistry, synthetic biology and material science have enabled the development of cell membrane-based drug delivery systems (DDSs), often referred to as artificial cellsor protocells. Artificial cells can be made by removing functions from natural systems in a top-down manner, or assembly from synthetic, organic or inorganic materials, through a bottom-up approach where simple units are integrated to form more complex structures. This review covers the latest advances in the development of artificial cells as DDSs, highlighting how their designs have been inspired by natural cells or cell membranes. Advancement of artificial cell technologies has led to a set of drug carriers with effective and controlled release of a variety of therapeutics for a range of diseases, and with increasing complexity they will have a greater impact on therapeutic designs. This journal is-
Descrição: dc.descriptionDepartment of Bioengineering Henry Samueli School of Engineering University of California, 420 Westwood Plaza, Engineering V-
Descrição: dc.descriptionDepartment of Chemistry Eskisehir Technical University-
Descrição: dc.descriptionDepartment of Bioprocess and Biotechnology Engineering São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo-
Descrição: dc.descriptionInstitute for Quantitative Health Science and Engineering (IQ) Department of Pharmacology and Toxicology College of Human Medicine Michigan State University-
Descrição: dc.descriptionInstitute of Pharmacy Faculty of Medicine University of Tartu, Nooruse Str. 1-
Descrição: dc.descriptionInstitute for Quantitative Health Science and Engineering (IQ) Departments of Biomedical Engineering (BME) Microbiology and Molecular Genetics Michigan State University-
Descrição: dc.descriptionInstitute for Quantitative Health Science and Engineering (IQ) Department of Biomedical Engineering (BME) Michigan State University-
Descrição: dc.descriptionDepartment of Bioprocess and Biotechnology Engineering São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo-
Formato: dc.format6672-6692-
Idioma: dc.languageen-
Relação: dc.relationMaterials Chemistry Frontiers-
???dc.source???: dc.sourceScopus-
Título: dc.titleUse of artificial cells as drug carriers-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.